H. Bischoff Et Al. , "First-line Treatment with Durvalumab and Platinum-Etoposide Combination for Patients with ED-SCLC: Exploratory Analyzes based on the Disease Extent in CASPIAN," PNEUMOLOGIE , vol.75, 2021
Bischoff, H. Et Al. 2021. First-line Treatment with Durvalumab and Platinum-Etoposide Combination for Patients with ED-SCLC: Exploratory Analyzes based on the Disease Extent in CASPIAN. PNEUMOLOGIE , vol.75 .
Bischoff, H., Reinmuth, N., Dvorkin, M., Garassino, M. C., Trukhin, D., Hochmair, M. J., ... ÖZGÜROĞLU, M.(2021). First-line Treatment with Durvalumab and Platinum-Etoposide Combination for Patients with ED-SCLC: Exploratory Analyzes based on the Disease Extent in CASPIAN. PNEUMOLOGIE , vol.75.
Bischoff, H. Et Al. "First-line Treatment with Durvalumab and Platinum-Etoposide Combination for Patients with ED-SCLC: Exploratory Analyzes based on the Disease Extent in CASPIAN," PNEUMOLOGIE , vol.75, 2021
Bischoff, H. Et Al. "First-line Treatment with Durvalumab and Platinum-Etoposide Combination for Patients with ED-SCLC: Exploratory Analyzes based on the Disease Extent in CASPIAN." PNEUMOLOGIE , vol.75, 2021
Bischoff, H. Et Al. (2021) . "First-line Treatment with Durvalumab and Platinum-Etoposide Combination for Patients with ED-SCLC: Exploratory Analyzes based on the Disease Extent in CASPIAN." PNEUMOLOGIE , vol.75.
@article{article, author={H. Bischoff Et Al. }, title={First-line Treatment with Durvalumab and Platinum-Etoposide Combination for Patients with ED-SCLC: Exploratory Analyzes based on the Disease Extent in CASPIAN}, journal={PNEUMOLOGIE}, year=2021}